Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Sep 15  •  04:00PM ET
0.8793
Dollar change
+0.0354
Percentage change
4.19
%
IndexRUT P/E- EPS (ttm)-0.23 Insider Own8.58% Shs Outstand37.78M Perf Week-11.46%
Market Cap33.24M Forward P/E- EPS next Y-0.26 Insider Trans9.04% Shs Float34.56M Perf Month-10.28%
Enterprise Value30.19M PEG- EPS next Q-0.11 Inst Own58.70% Short Float4.20% Perf Quarter-68.60%
Income-9.32M P/S0.82 EPS this Y-137.50% Inst Trans27.24% Short Ratio1.27 Perf Half Y-83.06%
Sales40.76M P/B1.89 EPS next Y30.92% ROA-33.99% Short Interest1.45M Perf YTD-86.35%
Book/sh0.47 P/C2.15 EPS next 5Y19.01% ROE-68.32% 52W High7.17 -87.74% Perf Year-78.45%
Cash/sh0.41 P/FCF- EPS past 3/5Y55.74% 62.04% ROIC-34.64% 52W Low0.81 9.23% Perf 3Y-50.32%
Dividend Est.- EV/EBITDA- Sales past 3/5Y32.93% 53.36% Gross Margin69.24% Volatility9.81% 8.37% Perf 5Y-75.84%
Dividend TTM- EV/Sales0.74 EPS Y/Y TTM13.25% Oper. Margin-22.85% ATR (14)0.10 Perf 10Y-
Dividend Ex-Date- Quick Ratio2.03 Sales Y/Y TTM93.07% Profit Margin-22.87% RSI (14)26.46 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio2.39 EPS Q/Q-271.33% SMA20-14.91% Beta1.50 Target Price3.75
Payout- Debt/Eq0.71 Sales Q/Q28.34% SMA50-42.88% Rel Volume2.53 Prev Close0.84
Employees185 LT Debt/Eq0.53 EarningsAug 11 AMC SMA200-77.98% Avg Volume1.14M Price0.88
IPOJun 12, 2017 Option/ShortYes / Yes EPS/Sales Surpr.-3.77% 5.53% Trades Volume2,884,900 Change4.19%
Date Action Analyst Rating Change Price Target Change
Jul-31-24Initiated Craig Hallum Buy $7
May-20-24Initiated Lake Street Buy $7
Dec-15-23Initiated H.C. Wainwright Buy $6.50
Nov-11-20Upgrade ROTH Capital Neutral → Buy $5 → $7
May-27-20Initiated Dougherty & Company Buy $8.50
Oct-02-17Initiated H.C. Wainwright Buy $12
Aug-12-25 03:00PM
Aug-11-25 07:00PM
04:05PM
Aug-08-25 09:32AM
Aug-04-25 04:05PM
12:40AM Loading…
Jul-10-25 12:40AM
Jun-25-25 08:56AM
Jun-18-25 08:30AM
May-08-25 03:31AM
May-07-25 09:00PM
09:00PM
06:25PM
05:11PM
May-01-25 08:30AM
Apr-30-25 04:05PM
08:05AM Loading…
08:05AM
Apr-10-25 08:30AM
Apr-09-25 06:03AM
Mar-31-25 04:05PM
Mar-11-25 01:12PM
03:03AM
Mar-10-25 05:15PM
04:05PM
Mar-07-25 07:06AM
Mar-03-25 04:05PM
Dec-05-24 07:30AM
Dec-04-24 04:05PM
Nov-07-24 02:22AM
Nov-06-24 06:00PM
04:05PM
08:07AM Loading…
Nov-05-24 08:07AM
Oct-31-24 04:05PM
Oct-30-24 04:05PM
Oct-18-24 05:01PM
Oct-09-24 05:08PM
04:05PM
Sep-12-24 08:30AM
Sep-05-24 04:15PM
Aug-06-24 04:05PM
Jul-30-24 04:05PM
Jul-27-24 07:40AM
Jul-26-24 06:05PM
Jul-08-24 08:30AM
Jun-11-24 10:50AM
Jun-05-24 05:58PM
Jun-01-24 02:42AM
May-17-24 07:01PM
May-10-24 04:03PM
01:01PM
May-09-24 01:16PM
May-08-24 04:05PM
May-06-24 01:19PM
08:30AM
May-01-24 05:21PM
Mar-28-24 04:05PM
Mar-18-24 11:00AM
Mar-08-24 10:15AM
Mar-07-24 06:00PM
04:05PM
Mar-01-24 08:00AM
Feb-29-24 04:05PM
Jan-19-24 04:05PM
Jan-17-24 08:05AM
08:00AM
Dec-20-23 08:50AM
Dec-12-23 07:00AM
Dec-01-23 10:00AM
Nov-20-23 04:16PM
Nov-08-23 11:47AM
Nov-07-23 04:05PM
Nov-06-23 08:30AM
Nov-02-23 10:08AM
Oct-31-23 04:05PM
Aug-29-23 04:05PM
Aug-28-23 12:38PM
Aug-25-23 07:00AM
Aug-24-23 07:33PM
04:15PM
04:05PM
Aug-21-23 04:05PM
Aug-09-23 05:30PM
04:05PM
Aug-02-23 04:05PM
Jul-05-23 10:50AM
Jul-03-23 08:30AM
Jun-14-23 04:05PM
May-22-23 09:55AM
May-10-23 06:05PM
May-09-23 07:05PM
May-05-23 07:45AM
May-03-23 04:05PM
Apr-10-23 08:30AM
Mar-16-23 05:30AM
Mar-15-23 08:30AM
Mar-14-23 11:11AM
Mar-13-23 09:45AM
08:30AM
Mar-07-23 10:12AM
Mar-06-23 04:05PM
Feb-06-23 04:05PM
Myomo, Inc. is a wearable medical robotics company, which engages in the business of developing, designing, and producing myoelectric orthotics for people with neuromuscular disorders. The firm is also involved in selling products through various other sales channels including through orthotics and prosthetics providers, veterans' administration, and to distributors in certain accounts and geographic markets. The company was founded by Stephen Kelly, John McBean, Mira Sahney, and Kailas N. Narendran on September 1, 2004 and is headquartered in Burlington, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KIRK THOMAS FDirectorAug 25 '25Buy1.1550,00057,500474,420Aug 26 08:10 AM
KIRK THOMAS FDirectorAug 18 '25Buy1.1050,00055,000424,420Aug 19 07:23 AM
GUDONIS PAUL RChief Executive OfficerAug 15 '25Buy0.9550,00047,2951,259,013Aug 18 07:51 AM
David HenryOfficerJun 30 '25Proposed Sale2.1923,58751,656Jun 30 08:12 PM
Harry KovelmanOfficerJun 28 '25Proposed Sale2.1913,05428,588Jun 30 08:04 PM
Harry KovelmanOfficerJun 06 '25Proposed Sale2.975,74317,057Jun 06 07:08 PM
David HenryOfficerJun 06 '25Proposed Sale2.978,37324,868Jun 06 06:50 PM
KIRK THOMAS FDirectorMay 15 '25Buy3.2536,824119,678344,700May 15 04:53 PM
KIRK THOMAS FDirectorMay 14 '25Buy3.251,9436,315307,876May 15 04:53 PM
GUDONIS PAUL RChief Executive OfficerMay 15 '25Buy3.2230,00096,6121,051,671May 15 04:36 PM
KIRK THOMAS FDirectorMay 12 '25Buy3.3550,000167,500305,933May 14 08:27 AM
KIRK THOMAS FDirectorMar 13 '25Buy5.007,40037,000255,933Mar 14 09:00 PM
Mitchell MicahChief Commercial OfficerMar 14 '25Sale5.1648,000247,565140,572Mar 14 05:36 PM
MICAH MITCHELLOfficerMar 14 '25Proposed Sale5.1648,000247,565Mar 14 05:24 PM
Kovelman HarryChief Medical OfficerMar 12 '25Sale5.5030,000165,01897,973Mar 13 04:41 PM
Micah MitchellOfficerMar 13 '25Proposed Sale5.221,2836,697Mar 13 04:31 PM
David HenryOfficerMar 13 '25Proposed Sale5.222,01910,539Mar 13 04:30 PM
Harry KovelmanOfficerMar 13 '25Proposed Sale5.221,4967,809Mar 13 04:28 PM
HARRY KOVELMANOfficerMar 12 '25Proposed Sale5.5030,000165,015Mar 12 04:59 PM
GUDONIS PAUL RChief Executive OfficerFeb 13 '25Option Exercise0.05694331,014,963Feb 18 04:33 PM
Harry KovelmanOfficerNov 04 '24Proposed Sale3.70121448Nov 04 03:19 PM
Harry KovelmanOfficerOct 03 '24Proposed Sale3.86121467Oct 03 12:54 PM